Total and partial cancer prevalence in the adult French population in 2008

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Colonna, Marc ^a,b   Mitton, Nicolas ^a   Bossard, Nadine ^c,d,e,f   Belot, Aurelien ^c,d,e,f,g,h   Grosclaude, Pascale ⁱ  

^a Isere's Cancer Registry   (France)

^b FRANCIM   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e UNIVERSITÉ DE LYON   (France)

^f LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^g INSTITUT DE VEILLE SANITAIRE   (France)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

ⁱ Centre Hospitalier spécialisé   (France)

Author keywords

Cancer burden; Incidence; Partial prevalence; Survival; Total prevalence

Indexed keywords

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; FRANCE; FRENCHMAN; GROUPS BY AGE; HODGKIN DISEASE; HUMAN; LIVER CANCER; LUNG CANCER; MALE; MELANOMA; OROPHARYNX CANCER; PANCREAS CANCER; PREVALENCE; PROSTATE CANCER; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER; HEALTH SURVEY; MIDDLE AGED; NEOPLASMS; PROCEDURES; REGISTER; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POPULATION SURVEILLANCE; PREVALENCE; REGISTRIES; YOUNG ADULT;

EID: 84925259237     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1168-2     Document Type: Article

References (27)

1. Giles G. How important are estimates of cancer prevalence? Ann Oncol. 2002;13:815-6.
2. Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman M, Hakulinen T, et al. Cancer prevalence in European registry areas. Ann Oncol. 2002;13:840-65.
3. Colonna M, Danzon A, Delafosse P, Mitton N, Bara S, Bouvier AM, et al. Cancer prevalence in France: Time trend, situation in 2002 and extrapolation to 2012. Eur J Cancer. 2008;44:115-22.
4. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al. NORDCAN - a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49:725-36.
5. Crocetti E, De Angelis R, Buzzoni C, Mariotto A, Storm H, Colonna M, et al. Cancer prevalence in USA, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability. Br J Cancer. 2013;109:219-28.
6. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133-45.
7. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97:72-81.
8. Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique. 2008;56:159-75.
9. Jooste V, Grosclaude P, Remontet L, Launoy G, Baldi I, Molinié F, et al. Unbiased estimates of long-term net survival of solid cancers in France. Int J Cancer. 2013;132:2370-7.
10. Bashir SA, Estève J. Analysis of the difference due to risk and demographic factors for incidence and mortality. Int J Epidemiol. 2002;29:878-84.
11. Estève J, Benhamou E, Raymond L. Statistical methods in cancer research, Vol. IV: descriptive epidemiology. Lyon: IARC Scientific Publication 128, International Agency for Research on Cancer; 1994. p. 37-44.
12. Coleman M, Estève J, Damiecki P, Arslan A, Renard H, et al. Trends in cancer incidence and mortality. Lyon: IARC Scientific Publications 121, International Agency for Research on Cancer; 1993. p. 27-38.
13. Remontet L, Estève J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidem et Sante Publique. 2003;51:3-30.
14. Uhry Z, Belot A, Colonna M, Bossard N, Rogel A, Iwaz J, et al. National cancer incidence is estimated using the incidence/mortality ratio in countries with local incidence data: is this estimation correct? Cancer Epidemiol. 2013;37:270-7.
15. Binder-Foucard F, Belot A, Delafosse P, Remontet L, Woronoff AS, Bossard N, et al. Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012. Partie 1 - Tumeurs solides. Saint-Maurice (Fra): Institut de veille sanitaire; 2013. p. 122.
16. Grosclaude P, Remontet L, Belot A, Danzon A, Rasamimanana C, Bossard N, et al. Survie des personnes atteintes de cancer en france, 1989-2007. Étude à partir des registres des cancers du réseau Francim. Saint-Maurice (Fra): Institut de veille sanitaire; 2013. p. 410.
17. Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R, et al. Cancer prevalence estimates in Europe at the beginning of 2000. Ann Oncol. 2013;24:1660-6.
18. Colonna M, Bossard N, Guizard AV, Remontet L, Grosclaude P, le réseau FRANCIM. Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival. Ann Endocrinol. 2010;71:95-101.
19. De Angelis R, Grande E, Inghelmann R, Francisci S, Micheli A, Baili P, et al. Cancer prevalence estimates in Italy from 1970 to 2010. Tumori. 2007;93:392-7.
20. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al. NORDCAN - Cancer Incidence, Mortality, Prevalence and Prediction in the Nordic Countries, Version 4. Association of the Nordic Cancer Registries. Danish Cancer Society. 2011. http://www.ancr.nu .
21. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al., editors. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010. http://seer.cancer.gov/csr/1975_2007/ based on November 2009 SEER data submission, posted to the SEER web site.
22. Chuang SC, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer. 2008;123:2390-6.
23. Chuang SC, Hashibe M, Scelo G, Brewster DH, Pukkala E, Friis S, et al. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev. 2008;17:1543-9.
24. Jégu J, Belot A, Borel C, Daubisse-Marliac L, Trétarre B, Granry O, et al. Survival of patients with second cancer of the head and neck with respect to their previous history of cancer. 2015. accepted for pubication in Oral Oncology.
25. Bouvier AM, David M, Jooste V, Chauvenet M, Lepage C, Faivre J. Rising Incidence of Pancreatic Cancer in France. Pancreas. 2010;39:1243-6.
26. Trétarre B, Remontet L, Ménégoz F, Macé-Lesec'h J, Grosclaude P, Buémi A. Ovarian cancer: incidence and mortality in France (in French). J Gynecol Obstet Biol Reprod. 2005;34:154-61.
27. Capocaccia R, Colonna M, Corazziari I, De Angelis R, Francisci S, Micheli A, et al. Measuring cancer prevalence in Europe: the EUROPREVAL project. Ann Oncol. 2002;13:831-9.